MIT's research enterprise in Singapore launches new research group, boosting nation's cell therapies R&D

MIT's Research Enterprise in Singapore, SMART, launches a new research group, Critical Analytics for Manufacturing Personalized-Medicine (CAMP), as part of Singapore's National Cell Manufacturing Initiative to overcome scientific and technical challenges in life-changing cell therapies. -- S$10 million a year to be invested in SMART CAMP in a multi-year effort -- New interdisciplinary research group, SMART CAMP, will bring together 35 MIT and Singapore investigators -- Complementary and integrated programme with Singapore's Agency for Science Technology and Research (A*STAR) cell manufacturing effort, supported by the National Research Foundation (NRF) -- SMART CAMP deploys MIT's innovation methodologies in Singapore's thriving biopharmaceutical industry, tapping market potential of billions a year.

TransCanna Terminates Transaction with Lifestyle Delivery Systems Inc.

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or the "Company") and Lifestyle Delivery Systems Inc. (CSE: LDS) (FSE: LD6) (WKN: A14XHT) (OTCQX: LDSYF) ("LDS") have mutually agreed to terminate a letter of intent ("LOI") dated June 28, 2019 whereby TransCanna was to acquire LDS. After careful review of the transaction and current market conditions, TransCanna has determined the acquisition of LDS by TransCanna under the terms of the LOI would not be in the best interests of shareholders, and as a result, the LOI has been terminated by both parties.

Novotech CRO partners Skin Research Institute of Singapore (SRIS) for Skin Disorder Research

ovotech, the award-winning Asia-Pacific CRO, has further strengthened its presence in the region through a Partnership with the Skin Research Institute of Singapore (SRIS). With this partnership, the two groups will be working together to promote combined capabilities in skin research clinical trials.

Global BioLife's new mosquito repellent formula performs well against mosquitos in independent testing

Singapore Exchange-listed Singapore eDevelopment Limited (Stock Code 40V) ("SeD") wishes to announce today that its U.S. biomedical subsidiary, Global BioLife Inc. ("Global BioLife"), has independently tested a new mosquito repellent formula which performs well against mosquitos for six (6) to eight (8) hours.

Transcanna creates hemp division; executes LOI with hemp based Biovelle

Transcanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or the "Company") is pleased to announce today the execution of a non-binding Letter Of Intent dated April 30th, 2019 to acquire the branding asset package, Biovelle, a hemp based CBD coconut oil from an arm's length third party.

Maharshi Atreya Health Centre - Well known Ayurvedic Health Centre in India

Maharshi Atreya Health Centre is a place of retreat for anyone seeking a genuine holistic experience for the well-being of body and mind. With a focus on authentic Ayurveda combined with today's possibilities of medical sciences, the Ayurvedic health centre offers best alternative to Western medicine.

Hemp, Inc. releases its 2018 Annual Report showing massive revenue increase over previous year

Hemp, Inc. (OTC PINK: HEMP) reported financial results for the quarter and full year ending December, 31, 2018. A global leader in the industrial hemp industry with bi-coastal processing centers including the 85,000 square-foot multipurpose industrial hemp processing facility in Spring Hope, North Carolina, a state of the art processing center in Medford, Oregon, and a 500-acre hemp growing Eco-Village in Golden Valley, Arizona, Hemp, Inc. showed over an 1,800% increase in sales from previous year 2017.

ReShape Lifesciences Announces Distribution in Australia

(ACN Newswire) - ReShape Lifesciences Inc. (OTCQB: RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced that as of April 1, 2019, the company is selling its LAP-BAND(R) product in the Australian market through a relationship with Satori Healthcare.

NutraLife Biosciences encouraged by cVS Health Corporation's decision to distribute CBD at 800 stores in the U.S.

NutraLife Biosciences, Inc. ("the Company" or "NutraLife") (OTCQB: NLBS) notes current trends in the retail space including CVS Health Corp.'s announcement that it will carry products containing CBD derived from hemp in about 800 of its U.S. drugstores.

NutraLife Bioscience, Inc. receives license to grow and process Industrial Hemp

NutraLife Biosciences, Inc. ("the Company" or "NutraLife") (OTCQB: NLBS) has received two licenses from the Wisconsin Department of Agriculture to grow and process industrial hemp within the state. The Company plans to develop efficient, cost reducing growing systems and processing technologies for industrial hemp.

NutraLife Biosciences, Inc. (OTCQB: NLBS) receives contract to provide its technologies and delivery system for Pharmaceutical Products by cGMP Pharmacy

NutraLife Biosciences, Inc. ("the Company" or "NutraLife") (OTCQB: NLBS) announces it has signed an agreement with Orlando Pharmacy, a USP 797 compliant compounding pharmacy, to provide its technologies and an innovative delivery system for pharmaceutical products.

Subcategories